Test Price
2,000 AED✅ Home Collection Available
Targeted Mutation Analysis (2 Mutations) in UAE | 2000 AED
MOHAP
APPROVED
Executive Summary & Core Metrics
Test Overview & Methodology
Targeted Mutation Analysis (2 Mutations) identifies two precisely designated gene variants using the gold‑standard Sanger sequencing method, providing definitive answers for hereditary cancer syndromes, prenatal diagnosis, and rheumatologic predisposition.
| Feature | Our UAE Advanced Test | Closest Alternative |
|---|---|---|
| Methodology | Sanger Sequencing (Gold Standard, single‑base resolution) | NGS panels (lower per‑variant depth) |
| Diagnostic Sensitivity | 99.9% for targeted mutations | 89–95% (may miss rare SNVs) |
| Turnaround Time | 10–15 days from collection | 3–4 weeks |
| Sample Types | Peripheral blood, plasma, serum, amniotic fluid, cord blood, chorionic villi | Often limited to blood/saliva |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), DHA‑MOHAP licensed | Varies, may be unaccredited |
Physician Insight & Safety Protocols
A note from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
“While this targeted analysis delivers near‑absolute certainty for the two mutations tested, it must be interpreted within your full clinical and family history. A negative result does not eliminate all genetic risk, and a positive finding should be discussed with a specialised physician to plan preventive or therapeutic steps.”
“I urge every patient to remember that no laboratory result replaces a comprehensive consultation—correlate these findings with imaging, physical examination, and personal health context.”
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Genetic test preparation may require temporary pausing of certain supplements; always follow your physician's advice.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria:
- Active chemotherapy or radiotherapy (must wait 4 weeks post‑treatment)
- Recent blood transfusion (< 2 weeks prior)
- Acute infection with high fever
- Known interfering anticoagulants not suspended (per physician guidance)
Seek Immediate Medical Care if:
- Severe bleeding or hematoma at collection site
- Signs of amniotic fluid leakage after invasive prenatal sampling
- Fever > 38.5°C post amniocentesis
- Sudden vision changes or numbness (rare embolic event)
Patient FAQ & Clinical Guidance
1. What exactly does Targeted Mutation Analysis (2 Mutations) detect and how reliable is it?
It detects the presence or absence of two specific DNA sequence variants using Sanger sequencing, delivering 99.9% analytical sensitivity and specificity.
2. Which specialists typically order this test and for what conditions?
Gynecologists, oncologists, and rheumatologists request it for hereditary breast/ovarian cancer syndromes, prenatal diagnosis, and genetic rheumatic disorders.
3. How is the sample collected and when will I receive my results?
A blood draw, amniotic fluid, or cord blood sample is taken within a hospital setting; results are securely delivered within 10–15 days via encrypted digital report.
4. Can I get this test done at home?
No. Because the specimen types include invasive prenatal fluids and cord blood, collection is strictly hospital-based for safety and clinical oversight.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Genomic data processed under strict data‑protection protocols; reports transmitted only via encrypted channels.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: All electronic health data handling and telephonic guidance comply with mandated security standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Clinical testing safety and patient consent requirements are fully observed.
- ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139): Quality management across all pre‑analytical, analytical and post‑analytical phases.
Clinical & Logistical Metadata
| Test Name | Targeted Mutation Analysis (2 Mutations) |
| Price (AED) | 2,000 AED |
| Turnaround Time | 10–15 days from receipt at the ISO‑certified laboratory |
| Sample Type / Matrix | Peripheral blood, plasma, serum, amniotic fluid, cord blood, chorionic villi |
| Methodology Used | Sanger Sequencing (Gold Standard, single‑base resolution) |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other specified genetic and chromosomal disorders) |
| LOINC Code | 81263-9 (Targeted mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians